Integrated gut microbiome and fecal metabolome profiling identifies taurine-associated microbial dysbiosis across the Alzheimer’s disease clinical spectrum
Gut microbiome alterations have been associated with Alzheimer’s disease (AD), but how microbial composition, fecal metabolites, and cognitive function relate across the cognitive impairment spectrum—from subjective cognitive decline (SCD) through mild cognitive impairment (MCI) to AD—remains unclear. We integrated...